Metabolic Bone Disease in Viral Cirrhosis: A Prospective Study

• Published in: ISRN Hepatology Vol. 2013; pp. 276563 - 6
• Main Authors: Goubraim, Rabia, Kabbaj, Nawal, Salihoun, Mouna, Chaoui, Zakia, Nya, M'Hamed, Amrani, Naima
• Format: Journal Article
• Language: English
• Published: United States Hindawi Publishing Corporation 21.04.2013
• Subjects: Clinical Study
• ISSN: 2314-4041; 2314-4041
• DOI: 10.1155/2013/276563

Background/Aim. Metabolic Bone disorders are well-recognized extrahepatic complications of cirrhosis. The aim was to report their prevalence and the associated factors to their development in patients with viral cirrhosis. Patients and Methods. All consecutive patients with viral cirrhosis were prospectively enrolled. Parathyroid hormone, 25-hydroxyvitamin D, liver function, and phosphocalcic tests were measured in all patients. Bone mineral density was measured at the lumbar spine and total hip by dual-energy X-ray absorptiometry. Data were analyzed using SPSS software. Results. Forty-six cirrhotic patients were included with hepatitis C (87%) and hepatitis B (13%). The Child-Pugh score was grade A in 87% of cases and grade B in 13%. Thirty-seven patients had decreased bone mineral density with osteopenia in 24 patients and osteoporosis in 13 patients. Decreased 25-hydroxyvitamin D was found in 95.6% of cases. Bone disorders were significantly more frequent in old patients with low body mass index, long duration of liver disease, and low 25-hydroxyvitamin D level. None of these factors was an independent factor associated with bone disorders. Conclusion. Our study revealed a high prevalence of metabolic bone disorders among viral cirrhotic patients. Consequently, bone mineral density assessment should be performed systematically in all cirrhotic patients.